RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Noninferiority of a Single-Tablet Combination HIV-1 Regimen Reported
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 28
SP 8
OP 9
DO 10.1177/155989771428003
UL http://mdc.sagepub.com/content/14/28/8.abstract
AB The Single Tablet Regimen (STaR) head-to-head comparison of anti-HIV-1 formulations has established the noninferiority of rilpivirine/emtricitabine/tenofovir DF (RPV/FTC/TDF) versus efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF) in HIV-1 virologic outcomes at weeks 48 and 96. The RPV/FTC/TDF combination was superior to EFV/FTC/TDF in terms of adverse effects and patient-reported outcomes.